US healthcare company CVS Health (NYSE:CVS) announced on Wednesday that its board of directors has approved a quarterly dividend of sixty-six and one-half cents (USD0.665) per share on its common stock.
This amount is unchanged from the previous quarterly dividend.
The dividend is payable on 3 November 2025, to holders of record as of 23 October 2025.
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement